Question · asked by 1 review
Roxithromycin vs placebo: Mean change from baseline of SNOT‐20 at 3 months post‐treatment Scale from: 0 to 5
- Population
- chronic rhinosinusitis in adults
- Intervention
- Roxithromycin
- Comparison
- placebo
- Outcome
- Mean change from baseline of SNOT‐20 at 3 months post‐treatment Scale from: 0 to 5
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Roxithromycin vs placebo Mean change from baseline of SNOT‐20 at 3 months post‐treatment Scale from: 0 to 5 · chronic rhinosinusitis in adults Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults (2011) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 64 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults 2011 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.